{"id":22460,"date":"2012-07-31T16:49:22","date_gmt":"2012-07-31T16:49:22","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/avancar-na-avaliacao-do-risco-de-doencas-infecciosas-emergentes-para-o-sangue-e-produtos-sanguineos-actas-de-um-seminario-publico\/"},"modified":"2024-06-05T21:18:51","modified_gmt":"2024-06-05T21:18:51","slug":"avancar-na-avaliacao-do-risco-de-doencas-infecciosas-emergentes-para-o-sangue-e-produtos-sanguineos-actas-de-um-seminario-publico","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/pt-pt\/resources\/avancar-na-avaliacao-do-risco-de-doencas-infecciosas-emergentes-para-o-sangue-e-produtos-sanguineos-actas-de-um-seminario-publico\/","title":{"rendered":"Avan\u00e7ar na avalia\u00e7\u00e3o do risco de doen\u00e7as infecciosas emergentes para o sangue e produtos sangu\u00edneos: actas de um semin\u00e1rio p\u00fablico."},"content":{"rendered":"\n<p>Gallagher LM, Ganz PR, Yang H, Kessler DA, O&#8217;Brien SF, Custer BS, Busch MP, Dodd RY, Stramer SL, Walderhaug MO, Forshee RA, Williams AE, Epstein JS, Anderson SA. Transfus\u00e3o. 2012 Jul 31. doi: 10.1111\/j.1537-2995.2012.03808.x.  [Epub ahead of print]<\/p>\n\n<p>Do Center for Biologics Evaluation and Research, US FDA, Rockville, Maryland; Health Canada, Ottawa, Ont\u00e1rio, Canad\u00e1; New York Blood Center, Nova Iorque, Nova Iorque; Canadian Blood Services, Ottawa, Ont\u00e1rio, Canad\u00e1; Blood Systems Research Institute, University of California San Francisco, San Francisco, Calif\u00f3rnia; e American Red Cross, Washington, DC.<\/p>\n\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22845334\" target=\"_blank\" rel=\"noopener\"><span lang=\"EN-US\">Nenhum resumo<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gallagher LM, Ganz PR, Yang H, Kessler DA, O&#8217;Brien SF, Custer BS, Busch MP, Dodd RY, Stramer SL, Walderhaug MO, Forshee RA, Williams AE, Epstein JS, Anderson SA. Transfus\u00e3o. 2012 Jul 31. doi: 10.1111\/j.1537-2995.2012.03808.x. [Epub ahead of print] Do Center for Biologics Evaluation and Research, US FDA, Rockville, Maryland; Health Canada, Ottawa, Ont\u00e1rio, Canad\u00e1; New <a href=\"https:\/\/patientbloodmanagement.org\/pt-pt\/resources\/avancar-na-avaliacao-do-risco-de-doencas-infecciosas-emergentes-para-o-sangue-e-produtos-sanguineos-actas-de-um-seminario-publico\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[325],"tags":[],"class_list":["post-22460","resources","type-resources","status-publish","hentry","category-seguranca-transfusional"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/resources\/22460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/media?parent=22460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/categories?post=22460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/pt-pt\/wp-json\/wp\/v2\/tags?post=22460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}